Solana Company·Healthcare

A veteran architect of Gemini's Asia Pacific expansion, Ms. Gani joins to lead institutional buildout as Solana Company executes on its strategy to drive yield expansion, enhance revenue generation, advance business diversification, and institutionalize the Solana ecosystem A veteran architect of Gemini's Asia Pacific expansion, Ms. Gani joins to lead institutional buildout as Solana Company executes on its strategy to drive yield expansion, enhance revenue generation, advance business diversification, and institutionalize the Solana ecosystem

Solana Company (HSDT) Q4 2025 Earnings Call Transcript

NEWTOWN, Pa., March 30, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury (“DAT”) dedicated to acquiring and holding Solana tokens (“SOL”), today announced results for the quarter and full year ended December 31, 2025.

NEWTOWN, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to acquiring and holding Solana (SOL), today announced that the Company will release its fourth quarter and full year operating results on Monday, March 30, 2026, after market close.

Solana (NASDAQ: HSDT - Get Free Report) will likely be announcing its Q4 2025 results before the market opens on Tuesday, March 24th. Analysts expect the company to announce earnings of ($26.50) per share and revenue of $0.14 million for the quarter. Interested persons may review the information on the company's upcoming Q4 2025 earning report

Solana Company (HSDT), Anchorage Digital, and Kamino collaborate to bring institutional capital to Solana's high-performance DeFi ecosystem through a first-of-its-kind tri-party custody model
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.